Dec 16 2010
Precision BioSciences, Inc., today announced that it has been awarded over $3 million across four government grants. These grants were each awarded to Precision during the 4th Quarter of 2010 and came from the National Institute of Standards and Technology, the Treasury Department, the National Institute of Health, and the State of North Carolina. Together, the grant funding will allow Precision to accelerate development of its proprietary genome engineering technology called the Directed Nuclease Editor (DNE).
“These grants will enable us to further refine applications of the technology, particularly as it pertains to cell line engineering.”
"Precision is poised to utilize DNE technology to address major challenges facing the biomanufacturing industry," said Michael Nicholson, Director of Cell Biology at Precision BioSciences. "These grants will enable us to further refine applications of the technology, particularly as it pertains to cell line engineering."
"We are thrilled to see that so many government funding agencies are recognizing the potential of our DNE technology," stated Derek Jantz, VP of Scientific Development at Precision. "We are grateful to all of those involved in making these awards to Precision."
Source: Precision BioSciences
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare